Skip to main content
Top
Published in: Reactions Weekly 1/2024

01-03-2024 | Graft-Versus-Host Disease | Case report

Prednisone/ruxolitinib/tacrolimus

Lack of efficacy

Published in: Reactions Weekly | Issue 1/2024

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Cai Y, et al. Case report: Pulse cyclophosphamide for treatment of multi-agent-refractory hepatic graft-versus-host disease. Frontiers in Oncology 14: Jan 2024. Available from: URL: https://dx.doi.org/10.3389/fonc.2024.1329893 Cai Y, et al. Case report: Pulse cyclophosphamide for treatment of multi-agent-refractory hepatic graft-versus-host disease. Frontiers in Oncology 14: Jan 2024. Available from: URL: https://​dx.​doi.​org/​10.​3389/​fonc.​2024.​1329893
Metadata
Title
Prednisone/ruxolitinib/tacrolimus
Lack of efficacy
Publication date
01-03-2024
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-55339-2

Other articles of this Issue 1/2024

Reactions Weekly 1/2024 Go to the issue

Case report

Fingolimod